Title of the centre:
WHO Collaborating Centre for Medicines Quality Assurance
Director / Head:
Dr Lisa Kerr
Ms Leisa Whitby
Institution:
Laboratories Branch
Therapeutic Goods Administration (TGA)
Address:
P.O. Box 100
2609
ACT
Town:
Woden
Country:
AUSTRALIA
Region:
WPRO
Phone:
(61-2) 62892132
Fax:
(61-2) 62031605
Date of Designation:
03/Mar/1987
Last Redesignation:
29/Nov/2022
Expiry:
29/Nov/2026
Date of Discontinuation:
Terms of Reference:
- Provide support to the WHO's programme of the International Pharmacopoeia, including support in the development and validation of test medicines
- Support WHO's work on quality assurance testing of medicine
- Provide scientific inputs to WHO on the quality assurance of medicines
- Support WHO's work towards developing test procedures for detecting substandard and falsified medicines.
-
-
-
-
-
-
Subjects:
- Pharmaceuticals (including essential drugs and medicines)
- Health Technology (including laboratory services; but excluding blood safety)
-
Types of activity:
- Providing technical advice to WHO
- Others
- Training and education
WHO Outputs:
| |
1.3.1 - Provision of authoritative guidance and standards on quality, safety and efficacy of health products, including through prequalification services, essential medicines and diagnostics lists |
| |
1.3.3 - Country and regional regulatory capacity strengthened, and supply of quality-assured and safe health products improved |
| |
1.1.5 - Countries enabled to strengthen their health workforce |
Responsible Officer:
LKHAGVADORJ Vanchinsuren
Phone:
+63 2 8528 8001
Technical Counterpart:
BALOCCO Raffaella Giovanna
Phone:
+41 22 791 3695
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
Link to eWork
|